| Mieke Denise Lane, DO | |
|
14508 Ne 20th Ave, Suite 300, Vancouver, WA 98686-6424 | |
| (360) 433-0022 | |
| (360) 433-6159 |
| Full Name | Mieke Denise Lane |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 24 Years |
| Location | 14508 Ne 20th Ave, Vancouver, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356390454 | NPI | - | NPPES |
| 278045 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | DO25698 (Oregon) | Secondary |
| 207V00000X | Obstetrics & Gynecology | OP00002124 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Legacy Salmon Creek Medical Center | Vancouver, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cascadia Womens Clinic Llp | 2062306996 | 5 |
News Archive
Researchers at the RIKEN Center for Brain Science have discovered a mutation that can protect against Alzheimer's disease in mice. Published in the scientific journal Nature Communications, the study found that a specific mutation can reduce the characteristic accumulation of the amyloid-beta peptide that occurs.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
In Sweden almost 40 000 children have now been born after IVF, around 3 500 each year, and IVF children constitute 3% of all newborns. "This represents a large number of children and any adverse outcomes related to IVF are therefore a major public health issue," said Dr. Antonina Sazonova, from Sahlgrenska University Hospital, Gothenburg, Sweden, who carried out the research with colleagues from the hospital and from Lund University.
An international group of researchers has shown that a regulatory protein involved in controlling how cancer spreads through the body also influences the fate of stem cells in the intestine of mice. The results, which are published in The EMBO Journal, show that the Snai1 protein plays an important role in deciding the fate of intestinal stem cells and the different functions that these cells can adopt.
› Verified 8 days ago
| Entity Name | Cascadia Womens Clinic Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942315304 PECOS PAC ID: 2062306996 Enrollment ID: O20040211000999 |
News Archive
Researchers at the RIKEN Center for Brain Science have discovered a mutation that can protect against Alzheimer's disease in mice. Published in the scientific journal Nature Communications, the study found that a specific mutation can reduce the characteristic accumulation of the amyloid-beta peptide that occurs.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
In Sweden almost 40 000 children have now been born after IVF, around 3 500 each year, and IVF children constitute 3% of all newborns. "This represents a large number of children and any adverse outcomes related to IVF are therefore a major public health issue," said Dr. Antonina Sazonova, from Sahlgrenska University Hospital, Gothenburg, Sweden, who carried out the research with colleagues from the hospital and from Lund University.
An international group of researchers has shown that a regulatory protein involved in controlling how cancer spreads through the body also influences the fate of stem cells in the intestine of mice. The results, which are published in The EMBO Journal, show that the Snai1 protein plays an important role in deciding the fate of intestinal stem cells and the different functions that these cells can adopt.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mieke Denise Lane, DO 14508 Ne 20th Ave, Suite 300, Vancouver, WA 98686-6424 Ph: (360) 433-0022 | Mieke Denise Lane, DO 14508 Ne 20th Ave, Suite 300, Vancouver, WA 98686-6424 Ph: (360) 433-0022 |
News Archive
Researchers at the RIKEN Center for Brain Science have discovered a mutation that can protect against Alzheimer's disease in mice. Published in the scientific journal Nature Communications, the study found that a specific mutation can reduce the characteristic accumulation of the amyloid-beta peptide that occurs.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
In Sweden almost 40 000 children have now been born after IVF, around 3 500 each year, and IVF children constitute 3% of all newborns. "This represents a large number of children and any adverse outcomes related to IVF are therefore a major public health issue," said Dr. Antonina Sazonova, from Sahlgrenska University Hospital, Gothenburg, Sweden, who carried out the research with colleagues from the hospital and from Lund University.
An international group of researchers has shown that a regulatory protein involved in controlling how cancer spreads through the body also influences the fate of stem cells in the intestine of mice. The results, which are published in The EMBO Journal, show that the Snai1 protein plays an important role in deciding the fate of intestinal stem cells and the different functions that these cells can adopt.
› Verified 8 days ago
Michelle Hocking De Geest, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 14406 Ne 20th Ave, Vancouver, WA 98686 Phone: 360-571-4244 Fax: 360-571-4246 | |
Richard T Kubiniec, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 14508 Ne 20th Ave Ste 300, Vancouver, WA 98686 Phone: 360-892-0208 Fax: 360-892-9081 | |
Anna Kerlin Bell-hibbs, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2525 Ne 139th St Ste 270, Vancouver, WA 98686 Phone: 360-882-2778 Fax: 360-604-1672 | |
Dr. Jennifer Catherine O'connor, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2101 Ne 139th St, Ste 350, Vancouver, WA 98686 Phone: 360-256-4060 Fax: 360-256-0103 | |
Dr. Lissa C Daimaru-enoki, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 14406 Ne 20th Ave, Vancouver, WA 98686 Phone: 360-571-4244 Fax: 360-571-4246 | |
Jonathan Erich, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Legacy Salmon Creek Hospital - Family Birth Center, 2211 N.e. 139th Street, Vancouver, WA 98686 Phone: 360-487-4295 | |
Michelle Eston Gruner, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 14406 Ne 20th Ave, Vancouver, WA 98686 Phone: 855-285-4246 Fax: 360-571-4246 |